Beam Therapeutics BEAM SEC Filings

NASDAQ BEAM
$29.83 +0.37 (+1.26%)
As of: Sep 4, 2026 · 2:24 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Beam Therapeutics Inc. (BEAM) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index